Verzenio 150 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ4W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,744
Award facts
- Contract value 100% obligated
- $34,743.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $34,743.65, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for VERZENIO 150 MG tablets in units of 14 to support federal medical procurement needs. The award, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, was funded by the Defense Logistics Agency and is non-competitive. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. This delivery order is issued under a larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare systems globally.
Amerisourcebergen Drug Corp, as the prime contractor under this IDC, regularly fulfills federal medical supply requirements across multiple therapeutic domains, including oncology, diabetes management, and pain management medications. The Defense Logistics Agency utilizes these contract vehicles to ensure consistent access to critical pharmaceutical commodities for military treatment facilities, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems. VERZENIO (abemaciclib) is a cyclin-dependent kinase inhibitor used in breast cancer treatment, reflecting the pharmaceutical distributor's role in supplying specialty medications essential to military and federal medical operations.
Quick answers
Who was awarded contract SPE2DR26FCZ4W?
SPE2DR26FCZ4W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ4W worth?
The government has obligated $34,744 on SPE2DR26FCZ4W.
Is contract SPE2DR26FCZ4W an order under another contract?
Yes. SPE2DR26FCZ4W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ4W competed?
The extent of competition for SPE2DR26FCZ4W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award